Literature DB >> 7898168

Volume versus wiring transmission in the brain: a new theoretical frame for neuropsychopharmacology.

L F Agnati1, B Bjelke, K Fuxe.   

Abstract

A volume transmission mode of communication in brain was implicit already in the early work of Golgi, who postulated the existence of electrical signals in the extracellular fluid (ECF) based on Volta's "wet conductor" made by solutions. The term volume transmission is taken from the term volume conduction describing the flow of ionic currents in the ECF as a basis for the electrocorticogram. The slow VT mode includes also chemical signals and is opposed to the fast synaptic (wiring) transmission. Every neuron may function in a dual mode, the synaptic and the volume transmission mode, when considering the autocrine and synaptic classes of communication. The paracrine- and neuroendocrine-like classes only involve the VT mode in the latter case including the CSF as a route. The chemical signals for VT are the neuropeptides, but also the classical transmitters, the monoamines, acetylcholine, GABA, and glutamate can participate, when they operate via slow, high affinity G protein coupled receptors. Ions such as K+, Ca++, and H+ also function as VT signals. The hypothesis is also introduced that CO2 can act as a multifacit long-distance VT and WT regulator besides being part of the CO2/HCO3 buffer. CO2 via regulating NMDA receptor sensitivity can also regulate NO formation, which represents a paracrine and fast VT signal. The therapy of CNS disorders is also discussed in the frame of the wiring and VT concept. Two therapeutical approaches can therefore be developed, one based on increasing WT and one based on increasing VT. In contrast to the WT therapy, which must preserve the electrotemporal code, the VT therapy can operate also with postsynaptic agonists. Therefore, a therapeutic effect with such a drug indicates that the deficiency in the communication process operates via VT. In view of the lack of very effective negative feedbacks in VT vs. WT, VT therapy may produce less tolerance and drug dependency.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7898168     DOI: 10.1002/med.2610150104

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  26 in total

1.  The Wiring Logic of an Identified Serotonergic Neuron That Spans Sensory Networks.

Authors:  Kaylynn E Coates; Steven A Calle-Schuler; Levi M Helmick; Victoria L Knotts; Brennah N Martik; Farzaan Salman; Lauren T Warner; Sophia V Valla; Davi D Bock; Andrew M Dacks
Journal:  J Neurosci       Date:  2020-07-08       Impact factor: 6.167

Review 2.  Spreading of pathology in neurodegenerative diseases: a focus on human studies.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2015-01-15       Impact factor: 34.870

Review 3.  Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-11-01       Impact factor: 10.005

4.  Serotonergic modulation across sensory modalities.

Authors:  Tyler R Sizemore; Laura M Hurley; Andrew M Dacks
Journal:  J Neurophysiol       Date:  2020-05-13       Impact factor: 2.714

Review 5.  Norepinephrine: a neuromodulator that boosts the function of multiple cell types to optimize CNS performance.

Authors:  John O'Donnell; Douglas Zeppenfeld; Evan McConnell; Salvador Pena; Maiken Nedergaard
Journal:  Neurochem Res       Date:  2012-06-21       Impact factor: 3.996

6.  Kinetics of ion channel modulation by cAMP in rat hippocampal neurones.

Authors:  Barrie Lancaster; Hua Hu; Barry Gibb; Johan F Storm
Journal:  J Physiol       Date:  2006-08-10       Impact factor: 5.182

7.  The regulation of brain states by neuroactive substances distributed via the cerebrospinal fluid; a review.

Authors:  Jan G Veening; Henk P Barendregt
Journal:  Cerebrospinal Fluid Res       Date:  2010-01-06

8.  Synaptic microcircuitry of tyrosine hydroxylase-containing neurons and terminals in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.

Authors:  Maney Mazloom; Yoland Smith
Journal:  J Comp Neurol       Date:  2006-04-01       Impact factor: 3.215

9.  Stimulation of orexin/hypocretin neurones by thyrotropin-releasing hormone.

Authors:  J Antonio González; Emilia Horjales-Araujo; Lars Fugger; Christian Broberger; Denis Burdakov
Journal:  J Physiol       Date:  2009-02-09       Impact factor: 5.182

10.  Gonadotropin-releasing hormone neuroterminals and their microenvironment in the median eminence: effects of aging and estradiol treatment.

Authors:  Weiling Yin; Di Wu; Megan L Noel; Andrea C Gore
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.